Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275 cancer drug candidate
March 27, 2024 02:30 ET
|
Vidac Pharma Holding PLC
Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275 cancer drug candidate London (UK), March 27, 2024 (07:30 CET) – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G;...
PlayMining GameFi Platform Launching New Game PicTrée Partnered with Japan’s Largest Electric Co. TEPCO Power Grid
March 21, 2024 04:16 ET
|
PlayMining
Global GameFi platform PlayMining to launch "GamifiedWork" Inspect-to-Earn game "PicTrée" in partnership with TEPCO PG, Japan's largest power company.
noco-noco and Neogen Forge Strategic Partnership to Unleash X-SEPA™ Technology in India's Burgeoning Battery Market (Projected to Exceed US$16 Billion by 2031)
March 07, 2024 19:00 ET
|
NOCO-NOCO PTE. LTD.
Singapore, March 08, 2024 (GLOBE NEWSWIRE) -- Highlights: Neogen secured a 3-year marketing and distribution license for noco-noco's X-SEPA™ technology with the eventual objective to...
REGENT Craft Announces Strategic Investment from H.I.S.
March 07, 2024 10:28 ET
|
REGENT
North Kingstown, RI, March 07, 2024 (GLOBE NEWSWIRE) -- REGENT, the manufacturer of all-electric seagliders for sustainable maritime mobility, today announced a strategic investment from H.I.S....
noco-noco and Neogen Forge Strategic Partnership to Unleash X-SEPA™ Technology in India's Burgeoning Battery Market (Projected to Exceed US$16billion by 2031)
March 07, 2024 10:04 ET
|
NOCO-NOCO PTE. LTD.
noco-noco and Neogen Forge Strategic Partnership to Unleash X-SEPA™ Technology in India's Burgeoning Battery Market (To Exceed US$16billion by 2031)
Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety and Efficacy, In Vivo
March 04, 2024 02:00 ET
|
Medigene AG
Planegg/Martinsried, March 4, 2024. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid...
Arcutis and Sato Announce Strategic Collaboration and Licensing Agreement for Topical Roflumilast in Japan
February 28, 2024 16:00 ET
|
Arcutis Biotherapeutics, Inc.
Arcutis and Sato today announced that the companies have entered into a strategic collaboration and licensing agreement for topical roflumilast in Japan.
Numab Therapeutics and Ono Pharmaceutical Announce an Option and Collaboration Agreement to Develop Multi-specific Antibody NM49 for Treatment of Cancer
February 14, 2024 03:00 ET
|
Numab Therapeutics AG
NM49 is a multi-specific antibody identified through Numab’s proprietary discovery and engineering technology platform designed to activate tumor associated macrophage phagocytosis Numab to receive...
Introducing Citeline’s TrialScope Disclose: Core Data
February 01, 2024 09:00 ET
|
Citeline
The new TrialScope Disclose: Core Data platform consolidates clinical trial disclosure for global registries, including ClinicalTrials.gov, CTIS and jRCT.
Travere Therapeutics Announces Licensing Agreement with Renalys Pharma to Develop and Commercialize Sparsentan in Japan, South Korea, Taiwan, and Southeast Asian Nations
January 25, 2024 16:05 ET
|
Travere Therapeutics, Inc.
Travere Therapeutics has entered into an exclusive licensing agreement with Renalys Pharma to bring sparsentan to patients in Japan.